Neoadjuvant Immunotherapy and Radiation Boosts Response in NSCLC
- Author
- ReachMD
- Published
- Fri 14 Mar 2025
- Episode Link
- https://reachmd.com/programs/medical-industry-feature/neoadjuvant-immunotherapy-and-radiation-boosts-response-in-nsclc/29913/
Guest: Nasser Altorki, M.D.
Nasser Altorki, MD, chief of thoracic surgery at NewYork-Presbyterian and Weill Cornell Medicine, shares the results of a first-of-its-kind study evaluating low-dose radiation combined with immunotherapy for neoadjuvant treatment of non-small cell lung cancer (NSCLC) tumors. The dual-therapy treatment of durvalumab in combination with stereotactic body radiation was almost twice as effective at tumor killing compared to durvalumab alone.
© 2025 NewYork-Presbyterian
